Cretostimogene Grenadenorepvec in BCG-Unresponsive NMIBC: A Discussion on the BOND-003 and CORE1 Trials - Trinity Bivalacqua
Trinity Bivalacqua
Sam Chang converses with Trinity Bivalacqua about treatments in non-muscle invasive bladder cancer, focusing on Cretostimogene grenadenorepvec (Creto), an oncolytic adenovirus, CG0070.
Addressing the Gaps in Quality of Life: A New Measure for Renal Cell Carcinoma Patients - Cristiane Bergerot
Cristiane Bergerot
Zach Klaassen interviews Cristiane Bergerot to explore health-related quality of life (HRQoL) in renal cell carcinoma patients, with Bergerot asserting that existing measures often overlook relevant aspects.